Diabetic Digest - September 13, 2017
I'm not one for diets. I think that people put too much emphasis on the word diet. Eating right and exercising regularly shouldn't be more than eating right and exercising regularly.
Saying that you're on a "diet" tells me that obviously you were unable to take care of your health and then you needed to really go to the extremes to help to improve yourself... or maybe you just in need of something to brag about.
I guess what I'm trying to say is that just take care of yourself don't make it a huge production. Take care of your health for you.
P.S. Did you miss an issue? You can read every issue from the Gophercentral library of newsletters on our exhaustive archives page. Thousands of issues, all of your favorite publications in chronological order. You can read AND comment. Just click GopherArchives
Comments? Questions? Email Steve
*-- Diabetic News --*
New trial will examine type 2 diabetes drug's effect on kidney function
WASHINGTON - Researchers are investigating the efficacy of sodium glucose co-transporter 2 inhibitors, a new class of drugs to treat type 2 diabetes, on kidney function.
Type 2 diabetes is known to have damaging effects on the kidneys and can result in kidney failure requiring dialysis or kidney transplant.
An ongoing second-phase drug trial called the CANVAS-R trial is testing the effects of canagliflozin, a sodium glucose co-transporter 2, or SGLT2, inhibitor in slowing the decline of kidney function in type 2 diabetes patients.
"CANVAS-R will greatly enhance our knowledge of the effects of canagliflozin on renal disease," Professor Bruce Neal of the George Institute of Global Health at the University of Sydney, Australia, lead author of the study, said in a press release. "In conjunction with the ongoing CANVAS trial, the data will also allow us to assess effects on hard vascular outcomes. The completion of the CANVAS program should approximately double the information we have about the effects of the SGLT2 inhibitor class on vascular disease."
The CANVAS study is examining canagliflozin's efficacy in reducing the risk of cardiovascular disease and major adverse cardiac events in type 2 diabetes patients.
The CANVAS-R study results will be combined with the CANVAS results to give doctors and patients recommendations on the use and benefits of canagliflozin.
The study was published in Diabetes, Obesity and Metabolism.
*-- Diabetic News --*
STUFFED MUSHROOM CHEDDAR BURGERS
1 1/2 pounds hamburger
1/4 cup finely diced onion
1/2 teaspoon salt
1/8 teaspoon pepper
2 tablespoons butter
1/2 pound sliced mushrooms
6 slices cheddar cheese
Combine the hamburger, onion, salt and pepper. Mix well. Saute mushrooms in butter until slightly browned and softened. Form meat mixture into 12 patties, about a quarter inch thick. Spoon about 1/6 of the mushrooms on to half the patties. Top with cheese and second patty. Seal around the edges, making sure that the patties are good and solid. Place on preheated grill and cook for a couple minutes per side will done. Serve immediately.
Missed an Issue? Visit the Diabetic Digest Archives